Pacira BioSciences
Yahoo Finance • 5 months ago
Pacira BioSciences Reports Second Quarter 2024 Financial Results
Pacira BioSciences -- Conference call today at 4:30 p.m. ET -- TAMPA, Fla., July 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative h... Full story
Yahoo Finance • 7 months ago
Earnings Miss: Pacira BioSciences, Inc. Missed EPS By 17% And Analysts Are Revising Their Forecasts
Investors in Pacira BioSciences, Inc. (NASDAQ:PCRX) had a good week, as its shares rose 9.3% to close at US$29.86 following the release of its quarterly results. It was not a great result overall. While revenues of US$167m were in line wit... Full story
Yahoo Finance • 10 months ago
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
Pacira BioSciences — Record revenues of $675 million in 2023 — — Full-year GAAP net income of $42 million and adjusted EBITDA of $214 million — — EXPAREL surpasses the 14 million patient mark — — Conference call today at 8:30 a.m. ET —... Full story
Yahoo Finance • last year
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
— EXPAREL is the only FDA-approved single-dose regional analgesic to safely demonstrate four days of superiority versus bupivacaine in two clinical studies — — New indications for use as an adductor canal block and sciatic nerve block in... Full story
Yahoo Finance • last year
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
TAMPA, Fla., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the following two healthcare conferences: Jefferies London Healthcare Con... Full story
Yahoo Finance • last year
Pacira BioSciences Inc (PCRX) Reports Q3 2023 Financial Results
Pacira BioSciences Inc (NASDAQ:PCRX) reported total revenues of $163.9 million in Q3 2023, a slight decrease from $167.5 million in Q3 2022. Net product sales for EXPAREL were $128.7 million, $28.8 million for ZILRETTA, and $5.3 million fo... Full story
Yahoo Finance • last year
Pacira BioSciences Reports Third Quarter 2023 Financial Results
-- New ASA initiatives to advance education and innovation for the anesthesia community -- -- PDUFA action date for EXPAREL as a lower extremity nerve block on track for November 13, 2023 -- -- Conference call today at 8:30 a.m. ET -- T... Full story
Yahoo Finance • last year
Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023
TAMPA, Fla., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its third quarter financial results before the open of the U.S. markets on Thursday November 2, 2023. Following the... Full story
Yahoo Finance • last year
American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
SCHAUMBERG, Ill. and TAMPA, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) today announced Pacira BioSciences, Inc. (Nasdaq: PCRX) has joined ASA’s Industry Supporter Program to support the Societ... Full story
Yahoo Finance • last year
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
-- Enhances diversity and expertise in key areas including scientific, commercial, and financial -- TAMPA, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opi... Full story
Yahoo Finance • last year
American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care
SCHAUMBURG, Ill. and TAMPA, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) and Pacira BioSciences, Inc. (Nasdaq: PCRX), today announced a new grant of $2.5 million, by Pacira to the ASA Charitable... Full story
Yahoo Finance • last year
Pacira BioSciences Announces Leadership Succession Plan
David Stack to Retire as Chairman and CEO Once Successor is Appointed Board Has Initiated Search for Successor TAMPA, Fla., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitme... Full story
Yahoo Finance • last year
Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference
TAMPA, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced its participation in an analyst-led fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference. The pre-recorded... Full story
Yahoo Finance • 2 years ago
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
TAMPA, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2023 RBC Capital Markets Global Healthcare Conference at 3:05 PM ET on... Full story
Yahoo Finance • 2 years ago
Pacira BioSciences Reports First Quarter 2023 Financial Results
-- EXPAREL continues to outperform elective surgery market with average daily volumes up 6 percent over prior year -- -- Conference call today at 8:30 a.m. ET -- TAMPA, Fla., May 03, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (N... Full story
Yahoo Finance • 2 years ago
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
TAMPA, Fla., April 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results before the open of the U.S. markets on Wednesday, May 3, 2023. Following the r... Full story
Yahoo Finance • 2 years ago
Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
TAMPA, Fla. and IRVING, Texas, April 20, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc., the industry leader in its commitment to non-opioid pain management and regenerative health solutions, and the Invited Celebrity Classic, an offi... Full story
Yahoo Finance • 2 years ago
Pacira BioSciences, Inc. Appoints Christopher Young as Chief Manufacturing Officer
TAMPA, Fla., April 19, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced the appointment of Christophe... Full story
Yahoo Finance • 2 years ago
Pacira BioSciences to Participate in Fireside Chat at the 22nd Annual Needham Virtual Healthcare Conference
TAMPA, Fla., April 12, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 22nd Annual Needham Virtual Healthcare Conference at 10:15 AM ET on W... Full story
Yahoo Finance • 2 years ago
Pacira BioSciences Announces Repayment and Termination of Term Loan B Facility Using Proceeds from New $150 Million 5-Year Term Loan A Facility and Existing Cash Resources
– Term Loan A Carries Significantly Lower Interest Rate – – Meaningfully Improves Debt Leverage Ratio and Reaffirms Outlook for Growth -- TAMPA, Fla., April 03, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the indu... Full story
